相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade
Christian Kuc et al.
MOLECULAR CARCINOGENESIS (2012)
COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells
Claudia Cerella et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Lung Cancer Chemoprevention with Celecoxib in Former Smokers
Jenny T. Mao et al.
CANCER PREVENTION RESEARCH (2011)
Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A2 and peroxisome proliferator-activated receptor gamma
Ming Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
The inhibitory effect of celecoxib on mouse hepatoma H22 cell line on the arachidonic acid metabolic pathway
Zhigang Xu et al.
BIOCHEMISTRY AND CELL BIOLOGY (2010)
Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
Edward S. Kim et al.
CANCER PREVENTION RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors
Vivek Vaish et al.
TUMOR BIOLOGY (2010)
Peroxisome Proliferator-Activated Receptor-γ Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis
Yun Dai et al.
CANCER RESEARCH (2009)
Cellular membranes function as a storage compartment for celecoxib
Thorsten J. Maier et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Activation of macrophage peroxisome proliferator-activated receptor-γ by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines
Samir S. Ayoub et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism
Heath A. Elrod et al.
MOLECULAR CANCER THERAPEUTICS (2009)
R(+)-Methanandamide-Induced Apoptosis of Human Cervical Carcinoma Cells Involves A Cyclooxygenase-2-Dependent Pathway
Karin Eichele et al.
PHARMACEUTICAL RESEARCH (2009)
The anti-proliferative potency of celecoxib is not a class effect of coxibs
Susanne Schiffmann et al.
BIOCHEMICAL PHARMACOLOGY (2008)
PPARγ is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells
Markus Schwab et al.
CARCINOGENESIS (2008)
15-deoxy-delta 12,14-prostaglandin J2 inhibits the synthesis of the acute phase protein SIP24 in cartilage:: Involvement of COX-2 in resolution of inflammation
Valentina Ulivi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib plus chemotherapy - Cancer and leukemia group B trial 30203
Martin J. Edelman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells
K. Eichele et al.
ONCOGENE (2008)
Involvement of PPARγ and E-cadherin/β-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells
Claudia Bocca et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Celecoxib toxicity is cell cycle phase specific
Jonathan M. Bock et al.
CANCER RESEARCH (2007)
15-Deoxy-Delta(12),(14)-prostaglandin J(2) enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors
Suniket V. Fulzele et al.
ANTI-CANCER DRUGS (2007)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Overexpression of Cox-2 in human osteosarcoma cells decreases proliferation and increases apoptosis
Zheng Xu et al.
CANCER RESEARCH (2006)
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
Sabine Groesch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549
SV Fulzele et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors
MS Shaik et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells
HK Na et al.
FEBS LETTERS (2005)
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products
J Kim et al.
CANCER RESEARCH (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cellular mechanisms of acetaminophen: role of cyclooxygenase
R Lucas et al.
FASEB JOURNAL (2005)
The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPAR gamma. Influence of albumin
M Lopez-Parra et al.
JOURNAL OF HEPATOLOGY (2005)
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni et al.
ONCOGENE (2004)
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck
ZG Chen et al.
CLINICAL CANCER RESEARCH (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits
N Hausman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbit
N Hausman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference
C Denkert et al.
ONCOGENE (2003)
Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation
HK Na et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer
NK Altorki et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells
AR Munkarah et al.
GYNECOLOGIC ONCOLOGY (2003)
Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors
N Kusunoki et al.
ARTHRITIS AND RHEUMATISM (2002)
Peroxisome proliferator-activated receptor-γ is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth
M Wick et al.
MOLECULAR PHARMACOLOGY (2002)
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
M Maccarrone et al.
BIOCHEMICAL JOURNAL (2002)
Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264
A Shibuya et al.
FEBS LETTERS (2002)
Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor γ in rheumatoid synovial cells
R Yamazaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells
DJE Elder et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
S Grösch et al.
FASEB JOURNAL (2001)
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
RA Gupta et al.
NATURE REVIEWS CANCER (2001)
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-κB
E Niederberger et al.
FASEB JOURNAL (2001)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
